A simple, intelligent way to support longevity, energy, and recoverywithout guesswork
Back Finan, B, Yang, B, Ottaway, N, et al (2015) 'A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents', Nature Medicine , 21, 27-26
GLP-1s and Endurance Performance: What Athletes Need to Know Dec 10, 2025 GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) have quickly gained attention for their dramatic effects on weight loss and appetite control
22 July 2022
It is not approved as a drug, supplement, or food ingredient in the US, EU, Australia, and similar markets
Therefore, it is vital to approach its use with caution